Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gallstones--do we know it all?].

Alan Patrick Ainsworth1

  • 1Odense Universitetshospital, Kirurgisk Afdeling A, Odense C. alan.ainsworth@dadlnet.dk

Ugeskrift for Laeger
|February 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of Combined Progression Index (CPI) in 132 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy.

Human pathology·2026
Same author

Prognostic value of baseline peritoneal fluid cytology in 224 patients with unresectable peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).

Human pathology·2025
Same author

Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis.

Pleura and peritoneum·2024
Same author

Implementation and evaluation of Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural effusion: study protocol for the Danish phase-I PITAC-OPC5 study.

Pleura and peritoneum·2024
Same author

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).

Pleura and peritoneum·2024
Same author

Short-term outcomes after minimally invasive oesophagectomy.

Danish medical journal·2019

This review addresses key questions in gallstone management, including rising cholecystectomy rates and diagnostic needs for common bile duct stones (CBDS). It questions the necessity of elective surgery after treating complicated gallstone disease.

Area of Science:

  • Gastroenterology
  • Hepatobiliary Surgery
  • Digestive Diseases

Context:

  • Gallstone disease remains a prevalent condition requiring effective management strategies.
  • Existing reviews on gallstone treatment leave several critical clinical questions unanswered.
  • Increasing rates of cholecystectomy highlight the need for refined treatment guidelines.

Purpose:

  • To critically evaluate current practices and unresolved issues in gallstone management.
  • To determine appropriate diagnostic work-up for common bile duct stones (CBDS) prior to cholecystectomy.
  • To assess the necessity of elective cholecystectomy after non-surgical or endoscopic treatment of complicated gallstone disease.

Summary:

  • This review synthesizes current knowledge on gallstone treatment, focusing on controversial areas.

Related Experiment Videos

  • It examines the rising incidence of cholecystectomies and identifies patient subgroups requiring further investigation for CBDS.
  • The necessity of elective cholecystectomy following conservative or endoscopic management of CBDS, acute pancreatitis, or acute cholecystitis is questioned.

    • Impact:

    • Provides clarity on complex gallstone treatment decisions, potentially optimizing patient care pathways.
    • Highlights areas where further research is crucial for evidence-based clinical practice.
    • Aims to reduce unnecessary surgical interventions and improve outcomes for patients with complicated gallstone disease.